Project CBD

FEBRUARY 28, 2023

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 5, 2022

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced that the U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc. 2 Goates et al. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

DECEMBER 30, 2019

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

NOVEMBER 16, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, announced today that it has received U.S. About MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

The Cannigma

JUNE 1, 2021

The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Children may be eligible in cases of refractory epilepsy or cancer. Who can get medical cannabis in France? .

Law 113

Law Epilepsy Programs Patients 113

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states. We need to do more.

Marijuana 208

Marijuana Legalization Programs Oil 208

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Veriheal

JANUARY 15, 2021

So does that mean that there is no access to THC for patients in the country? The Medical Cannabis Access Programme. In 2019 Ireland’s Health Minister Simon Harris signed legislation known as the Misuse of Drugs, Prescriptions, and Control of Supply of Cannabis for Medical Use Regulations 2019. Not exactly.

Legalization 57

Legalization Therapy Access Legislation 57

WeedAdvisor

SEPTEMBER 26, 2019

Created for the treatment of two severe childhood epilepsy disorders – Lennox Gastaut Syndrome (LGS) and Dravet Syndrome – the drug recently received approval for use in the European Union. million in the first half of 2019. Zynerba Pharmaceuticals is currently working on its own CBD medication called Zygel.

CBD 40

CBD Pharmaceutical Research and Development Epilepsy 40

Cannabis Law Report

DECEMBER 14, 2019

12, 2019 (GLOBE NEWSWIRE) — AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) ( PU31.F VANCOUVER, British Columbia, Dec. The UK medicinal cannabis market value is forecast to reach almost US$1.3 billion by 2024. Prohibition Partners estimates that there are as many as 3.6

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. Millions of individuals are reporting CBD having aided in helping them with: Anxiety.

Pets 59

Pets CBD Research and Development Epilepsy 59

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

JANUARY 15, 2020

million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company. . Consumers are currently aware of the therapeutic benefits of cannabis, but cannot easily access quality solutions.

CBD 64

CBD Epilepsy Chronic Pain Treatment 64

The Cannigma

OCTOBER 20, 2021

The agency does not have an official list of health conditions that are eligible for treatment with medical cannabis, but the doctor is required to provide justification for why conventional pharmaceuticals won’t suffice for the patient, and their assessment of why the patient may benefit from medical cannabis. In addition, 29.2%

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Across the longitudinal period, we found that most reports carried a positive tone towards medicinal cannabis. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

NOVEMBER 22, 2019

In Brazil, the initial step to allow the use of cannabis sativa for medical purposes was taken in 2014, when the Judiciary granted the first injunction to authorize a patient to import and use cannabidiol-rich oil (CBD) for the refractory epilepsy treatment. plant or substances obtained from it in its composition. Source: [link].

Sativa 59

Sativa Medicine Legalization Epilepsy 59

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

CannaTech

MARCH 29, 2019

In a tragic-ironic twist, whilst patients are struggling for access, the country has no shortage of cannabis. ” In other words, if you think you will be getting access to legal marijuana in the UK any time soon, think again. .” The UK is the World’s Largest Cannabis Exporter. Only specialist (sic.

Chronic Pain 50

Chronic Pain Access Patients Food 50

Veriheal

OCTOBER 1, 2020

Cannabis is easily accessible, and the regulations are loosening up quite a bit. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy. It proposes that cannabis can strictly be accessed by prescription alone. .

Legalization 104

Legalization Oil Medicine Media 104

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. Executive producer, Michael Schaeffer Omer-Man. Music by Desca. MSO: Wait, hold on.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. A 2019 study found that 76% of patients in the U.S. Access to Better Products. More Telemedicine.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? dried flower and oils) are now clearly considered as a separate and distinct class od products.

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

FEBRUARY 1, 2020

More than 50 countries worldwide now permit access to regulated medical marijuana, and several nations–like South Africa and Mexico–have even legalised cultivation for personal use. We’ve identified the 5 nations in the region that offer the greatest access to legal marijuana. The Article. billion by the end of 2026. NEW ZEALAND.

Legalization 59

Legalization Research and Development Recreational Access 59

Cannabis Law Report

JUNE 26, 2019

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. There is some help in sight, though.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Shutterstock). It’s everywhere. An anti-seizure wonder drug.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

SEPTEMBER 19, 2019

Joshua Warner | Writer , London | Wednesday 18 September 2019 00:53. Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. GW Pharmaceuticals.

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

MAY 7, 2019

Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Liht’s ability to access private and public capital could be affected and or could not be available to support continuing operations. March 04, 2019 13:32 ET | Source: Veritas Pharma Inc. Veritas Pharma Inc.

Compliance 63

Compliance Compliance Research and Development Strains 63

The Cannigma

AUGUST 29, 2021

The AARP, explaining its 2019 policy change, stated that its decision was based on “the growing body of research suggesting marijuana may be helpful in treating certain medical conditions and symptoms.”. Access to healthcare professionals. Get your medical card now with The Cannigma Medical.

Blood Pressure 87

Blood Pressure Marijuana Conditions Sleep 87

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

OCTOBER 26, 2019

iv Named-patient and compassionate use proceduresThe TG Act provides mechanisms that allow individuals to gain limited access to UTGs (defined in Section II.iii). The Special Access Scheme (SAS) provides three pathways for access to UTGs: a Category A is a notification pathway that can only be accessed by medical practitioners (i.e.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

JULY 15, 2022

They then go off to their separate sections, which are again all controlled by biometric fingerprint scanning for access,” Mr Benjamin said. Workers will have their fingerprints scanned before being allowed to access the turnstile to the Medifarm facility. ( Media event date: 27 August 2019. “They get changed.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

APRIL 22, 2019

The rules don’t specify the country of origin of the prescription, but they do require travellers to have accessed the drug through a pharmacist. Under current federal and state legislation, patients suffering from severe health conditions can legally access prescription-based medicinal cannabis in Australia.

Chronic Pain 10

Chronic Pain Medicine Conditions Access 10

Cannabis Law Report

OCTOBER 17, 2019

When the first physical stores opened six months later in April 2019, legal recreational cannabis sales in the province more than doubled online sales from the previous two months. In June 2019, the country released its regulations for other forms of cannabis, from topicals to extracts to edibles, which become legal on October 17, 2019.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

MAY 17, 2019

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 Budgeted at $6.1 billion (a $643.1 Budgeted at $6.1 billion (a $643.1

Food 10

Food DEA Hemp CBD 10